Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.31 $4.00 Thursday, 9th May 2024 CYCC stock ended at $2.31. This is 0.431% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 14.48% from a day low at $2.27 to a day high of $2.60.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Oct 20, 2016 $4.87 $5.18 $4.81 $5.05 19 000
Oct 19, 2016 $4.82 $4.93 $4.60 $4.93 59 400
Oct 18, 2016 $5.13 $5.24 $4.80 $4.85 203 800
Oct 17, 2016 $5.20 $5.38 $5.01 $5.04 139 800
Oct 14, 2016 $5.27 $5.43 $5.07 $5.20 110 500
Oct 13, 2016 $5.16 $5.45 $5.05 $5.25 334 600
Oct 12, 2016 $5.49 $5.63 $5.21 $5.26 89 000
Oct 11, 2016 $5.57 $5.79 $5.50 $5.52 97 600
Oct 10, 2016 $5.47 $5.83 $5.47 $5.66 187 400
Oct 07, 2016 $5.57 $5.60 $5.33 $5.47 81 100
Oct 06, 2016 $5.80 $5.87 $5.50 $5.61 81 800
Oct 05, 2016 $5.63 $5.95 $5.37 $5.79 90 000
Oct 04, 2016 $5.91 $5.98 $5.50 $5.58 89 900
Oct 03, 2016 $6.01 $6.03 $5.90 $5.95 100 300
Sep 30, 2016 $6.02 $6.08 $5.92 $6.00 84 200
Sep 29, 2016 $6.10 $6.19 $5.83 $6.01 455 600
Sep 28, 2016 $5.71 $6.15 $5.58 $6.00 428 900
Sep 27, 2016 $5.59 $5.79 $5.40 $5.76 157 900
Sep 26, 2016 $5.53 $5.75 $5.53 $5.66 81 700
Sep 23, 2016 $5.84 $5.89 $5.51 $5.62 63 600
Sep 22, 2016 $5.96 $5.96 $5.60 $5.82 103 700
Sep 21, 2016 $6.06 $6.13 $5.71 $5.88 348 200
Sep 20, 2016 $5.49 $6.19 $5.49 $5.98 593 200
Sep 19, 2016 $5.75 $5.87 $5.40 $5.48 264 000
Sep 16, 2016 $5.10 $5.67 $4.91 $5.40 270 800
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT